EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY-NC-ND 4.0

Treatment of post‐treatment Lyme disease symptoms—a systematic review

Rick Dersch iD, Gabriel Torbahn iD, Sebastian Rauer

European Journal of Neurology · 2024-07 · 31 (7)

DOI: 10.1111/ene.16293 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift European Journal of Neurology, online erschienen am 12.04.2024. Verfasst von Rick Dersch und 2 weiteren Autor:innen. Beteiligte Einrichtung: Clinic of Neurology and Neurophysiology, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany. Hauptthemen laut MEDLINE: Lyme Disease. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: German Neurological Society.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and purpose Residual symptoms after treatment of Lyme disease, sometimes called post‐treatment Lyme disease symptoms (PTLDs), are a matter of ongoing controversy. To guide treatment recommendations, a systematic review was performed of the available literature on specific treatment for PTLDs.

Methods

A systematic literature search of MEDLINE and CENTRAL was performed. No restrictions on case definitions, study types or specific interventions were applied to enable a comprehensive overview of the available literature. Risk of bias was assessed using the Cochrane risk of bias tools for randomized controlled trials. Certainty of the evidence was assessed using the Grading of Recommendations, Assessment, Development and Evaluation approach. Outcomes of interest were quality of life, fatigue, depression and cognition as well as adverse events.

Results

After screening 1274 records, eight eligible randomized controlled trials were included. Heterogeneity was observed regarding inclusion criteria, intervention, length of treatment and outcome measures. For efficacy outcomes, results are presented narratively due to heterogeneity. Eligible studies show no statistically significant difference between antibiotics and placebo regarding quality of life, cognition and depression. Results for fatigue were inconsistent whilst studies with low risk of bias showed no statistically significant difference between antibiotics and placebo. Meta‐analysis of safety outcomes showed statistically significantly more adverse events for antibiotics compared to placebo.

Conclusions

Available literature on treatment of PTLDs is heterogeneous, but overall shows evidence of no effect of antibiotics regarding quality of life, depression, cognition and fatigue whilst showing more adverse events. Patients with suspected PTLDs should not be treated with antibiotics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lyme DiseaseHumansPost-Lyme Disease SyndromeAnti-Bacterial AgentsQuality of LifeRandomized Controlled Trials as TopicDepression

Stichwörter der Autor:innen

Lyme diseaseLyme neuroborreliosisfatiguepost‐treatment Lyme disease syndromesystematic review

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • Clinic of Neurology and Neurophysiology, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Department of Pediatrics, Paracelsus Medical University, Klinikum Nürnberg, Universitätsklinik der Paracelsus Medizinischen Privatuniversität Nürnberg, Nuremberg, Germany.

ORCID-Profile: Rick Dersch, Gabriel Torbahn

Förderung

  • German Neurological Society

Zitieren

APA

Dersch, R., Torbahn, G., & Rauer, S. (2024). Treatment of post‐treatment Lyme disease symptoms—a systematic review. European Journal of Neurology, 31(7). https://doi.org/10.1111/ene.16293

Vancouver

Dersch R, Torbahn G, Rauer S. Treatment of post‐treatment Lyme disease symptoms—a systematic review. European Journal of Neurology. 2024;31(7). doi:10.1111/ene.16293

BibTeX
@article{Dersch2024,
  author = {Dersch, Rick and Torbahn, Gabriel and Rauer, Sebastian},
  title = {Treatment of post‐treatment Lyme disease symptoms—a systematic review},
  journal = {European Journal of Neurology},
  year = {2024},
  volume = {31},
  number = {7},
  doi = {10.1111/ene.16293}
}
Infokarte | EUVIMED

Artikeldaten derzeit nicht verfügbar.

Recherche